IP Library Granted Patent US 11,732,251
Granted Patent B2
US 11,732,251 · App. 16/607,849 · Granted Aug 22, 2023

Anti-CRISPR polynucleotides and polypeptides and methods of use

Inventors: Christophe Fremaux (Poitiers, FR); Philippe Horvath (Châtellerault, FR); Alexander Hynes (Québec City, CA); Marie-Laurence Lemay (Quebec City, CA); Sylvain Moineau (Quebec City, CA); Dennis A. Romero (Oregon, WI); Geneviève Rousseau (Québec City, CA); Joshua K Young (Johnston, IA)
Assignees: DUPONT NUTRITION BIOSCIENCES APS; UNIVERSITE LAVAL (CANADA)
C12N9/22C07K14/005C07K14/315C12N15/63C12N2795/10322
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,732,251
App. No.
16/607,849
Granted
Aug 22, 2023
Kind
B2
Abstract

Methods and compositions are provided for the use of anti-CRISPR (ACR) proteins in plants, including modulation of Cas endonuclease activity, improvement of frequency of homologous recombination, control of Cas endonuclease activity during various cell cycles, spatial and/or temporal regulation of Cas endonuclease activity in plants, usage in gene activation or repression, as well as reduction of off-target polynucleotide cleavage.

Claims (4)

1. A method for modulating the activity of a Cas endonuclease with a target polynucleotide in a cell, comprising providing an anti-CRISPR (ACR) polypeptide having an amino acid sequence at least 90% identical to SEQ ID NO:8 to the cell, wherein the ACR polypeptide decreases the activity of the Cas endonuclease in the cell compared to a control cell comprising the Cas endonuclease but not comprising the ACR polypeptide.

2. The method of claim 1 , wherein the Cas endonuclease activity is selected from the group consisting of target polynucleotide binding, target polynucleotide nicking, target polynucleotide double-strand-break creation, and target polynucleotide modification.

3. The method of claim 2 , wherein said target polynucleotide modification is selected from the group consisting of insertion of at least one nucleotide, deletion of at least one nucleotide, substitution of at least one nucleotide, and chemical alteration of at least one nucleotide.

4. The method of claim 1 , wherein the cell is selected from the group consisting of a plant cell, an animal cell, a mammalian cell, a microbial cell and a fungal cell.

Assignments (6)
CHANGE OF NAME Recorded Feb 6, 2024
From: DUPONT NUTRITION BIOSCIENCES APS
To: INTERNATIONAL N&H DENMARK APS
Reel/Frame 066494/0814 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2023
From: DANISCO FRANCE SAS
To: DUPONT NUTRITION BIOSCIENCES APS
Reel/Frame 064108/0228 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2023
From: DANISCO USA INC.
To: DUPONT NUTRITION BIOSCIENCES APS
Reel/Frame 064108/0254 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2023
From: HORVATH, PHILIPPE; FREMAUX, CHRISTOPHE
To: DANISCO FRANCE SAS
Reel/Frame 064097/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2023
From: ROMERO, DENNIS A.; YOUNG, JOSHUA K.
To: DANISCO USA INC.
Reel/Frame 064097/0733 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2023
From: HYNES, ALEXANDER; LEMAY, MARIE-LAURENCE; MOINEAU, SLYVAIN; ROUSSEAU, GENEVIEVE
To: UNIVERSITÉ LAVAL
Reel/Frame 064097/0813 →